Skip Page Header

Home > Drugs of dependence: The role of medical professionals.

BMA Science and Education department and the Board of Science.. (2013) Drugs of dependence: The role of medical professionals. London: British Medical Association.

[img]
Preview
PDF (Drugs of dependence: the role of medical professionals) - Submitted Version
1MB

External website: http://bma.org.uk/news-views-analysis/in-depth-dru...

Executive summary
• Chapter 1 - Introduction
• Chapter 2 - The scale of the problem: illicit drug use in the UK
• Chapter 3 - The burden of illicit drug use
• Chapter 4 - Influences on illicit drug use
• Chapter 5 - Drug policy in the UK: from the 19th century to the present day
• Chapter 6 - Controlling illicit drug use
• Chapter 7 - Delaying initiation and minimising the use of illicit drugs
• Chapter 8 - Medical management of drug dependence: the doctor's role in managing heroin addiction
• Chapter 9 - Medical management of drug dependence: reducing secondary health harms
• Chapter 10 - Medical management of drug dependence in the context of criminal justice: illicit drug use, courts and prison
• Chapter 11 - The role of healthcare professionals

Appendix 1: Membership of the BMA Board of Science Reference Group
Appendix 2: The nature and addictiveness of commonly used illicit drugs
Appendix 3: Health-related harms of emerging and established licit and illicit drugs commonly used in the UK
Appendix 4: UK illicit drug usage data
Appendix 5: Overview of drug adulterants
Appendix 6: UK government strategies for reducing illicit drug use
Appendix 7: Societal measures to restrict drug influences
References

This publication contains a very useful glossary of terms.


Item Type
Report
Publication Type
International, Guideline, Report
Drug Type
All substances
Intervention Type
General / Comprehensive, Drug therapy, Treatment method, Alternative medical treatment, Prevention, Harm reduction, Education and training, Psychosocial treatment method, Rehabilitation/Recovery, Screening / Assessment
Date
January 2013
Pages
341 p.
Publisher
British Medical Association
Corporate Creators
BMA Science and Education department and the Board of Science.
Place of Publication
London
EndNote
Accession Number
HRB (Electronic Only)
Subjects
A Substance use and dependence > Effects and consequences
A Substance use and dependence > Substance related societal (social) problems
B Substances > Opioids (opiates)
G Health and disease > State of health
G Health and disease > Substance use disorder > Multiple substance use (Poly-drug /Poly-substance)
HJ Treatment method > Substance disorder treatment method
HJ Treatment method > Substance disorder treatment method > Substance disorder drug therapy
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
HJ Treatment method > Psychosocial treatment method
J Health care, prevention, harm reduction and rehabilitation > Risk and protective factors > Risk factors
J Health care, prevention, harm reduction and rehabilitation > Harm reduction > Substance use harm reduction
J Health care, prevention, harm reduction and rehabilitation > Substance use prevention > Universal prevention
J Health care, prevention, harm reduction and rehabilitation > Substance use prevention > Targeted prevention
J Health care, prevention, harm reduction and rehabilitation > Treatment and maintenance > Provider / worker / staff attitude toward treatment
J Health care, prevention, harm reduction and rehabilitation > Health care delivery
J Health care, prevention, harm reduction and rehabilitation > Health care programme, service or facility > Prison-based health service
J Health care, prevention, harm reduction and rehabilitation > Health care programme, service or facility > Community-based treatment (primary care)
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
MP-MR Policy, planning, economics, work and social services > Economic aspects of substance use (cost / pricing)
N Communication, information and education > Recommendations > Practice / clinical guidelines
T Demographic characteristics > Doctor
VA Geographic area > Europe > United Kingdom

Repository Staff Only: item control page